跳至主要内容
临床试验/NL-OMON50529
NL-OMON50529招募中不适用

ew strategies to detect cancers in carriers of mutations in RB1: blood tests based on tumor-educated platelets, or extracellular vesicles. - NIRBTEST

Vrije Universiteit Medisch Centrum0 个研究点目标入组 91 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
91

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 99(—)

入选标准

  • Group 1: germline mutation RB1
  • Group 2 (control): no germline mutation RB1
  • - Pediatric:
  • Group 1: mutation RB1 and retinoblastoma
  • Group 2 (control): no mutation RB1

排除标准

  • Group 1: concomitant heritable (inherited) disorder other than caused by
  • monoallelic mutation of RB1
  • Group 2 (control): cancer or already known cancer predisposition syndrome
  • - Pediatric:
  • Group 1: concomitant heritable (inherited) disorder other than caused by
  • monoallelic mutation of RB1
  • Group 2: cancer or already known cancer predisposition syndrome

研究者

相似试验

ew strategies to detect cancers in carriers of... | 临床试验